NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ligence

Ligence

Private
KaunasHealthcare & Life Scienceshttps://ligence.io/

Last Round

Grant

Feb 13, 2026

Total Funding Raised

$3.74M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ligence is a health-tech company that provides an AI-powered software platform to automate the analysis and reporting of heart ultrasound images.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

echocardiography AIAI echoautomated echo analysisSoftware as a Medical DeviceSaMDmedical imaging AIcardiology AIcardiac reporting softwareglobal longitudinal strainLV GLSTTE analysisPACS integrationFDA clearanceCE mark softwareEHR integrationmedical computer vision

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ligence Comparables

Compare Ligence with similar companies based on industry and business-model similarity.

Ligence comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Ligence Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 13, 2026
SeedNov 12, 2024
GrantOct 29, 2020
Pre SeedAug 18, 2020

Key People

Founding team and executive leadership

Arnas Karužas

Chief Executive Officer

Executive Team

Dmitrij Abolichin

Chief Technology Officer

Executive Team

Dovydas Matuliauskas

CFO & Business Development Manager, Business Development Manager

Executive Team

Justinas Balčiūnas

Chief Operating Officer

Executive Team

Ligence Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2026

    $55K grant received from the European Union.

  • Jan 20, 2025

    Grew 22% QoQ, from 18 to 22 employees.

Ligence Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ligence Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ligence's valuation, stock price, and market status.

Firmographic Details

HeadquartersKaunas
Employee Range29
Year Founded2019
Last FundingFeb 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.